Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference25 articles.
1. Radiotherapy of squamous, adeno- and large cell carcinoma of the lung;Kjaer;Cancer Treat Rev,1992
2. Conservative resection in surgery for bronchogenic carcinoma;Thaupsa;J Thorac Cardiovasc Surg,1967
3. Impact of irradiated technique and tumour extent in tumour control and survival of patients with unresectable oat cell carcinoma of the lung;Perez;Cancer,1982
4. Prognostic factors of inoperable localized lung cancer treated by high-dose radiotherapy;Schaake-Koning;Int J Radiat Oncol Biol Phys,1983
5. Effects of concomitant cisplatin and radiotherapy in inoperable nonsmall-cell lung cancer A randomized phase III study of the EORTC Radiotherapy and Lung Cancer Cooperative Group;Schaake-Koning;N Engl J Med,1992
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients;Frontiers in Pharmacology;2020-06-26
2. Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC : A systematic review;Thoracic Cancer;2020-04-22
3. Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2018-11
4. From Cisplatin-Containing Sequential Radiochemotherapy towards Concurrent Treatment for Patients with Inoperable Locoregional Non-Small Cell Lung Cancer: Still Unanswered Questions;Chemotherapy Research and Practice;2010-12-28
5. Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer;Radiation Oncology;2007-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3